Mixing Semaglutide: Separating Fact From a Dangerous Misconception

The misconception: that mixing is a normal part of using semaglutide

Search for semaglutide and you will quickly find detailed instructions on reconstituting a powder, choosing between bacteriostatic and sterile water, drawing up doses with syringes, and calculating concentrations. Pages explaining a semaglutide mixing chart or a semaglutide mixing calculator exist because compounded semaglutide (produced in powder form by compounding pharmacies) became widely available in the United States, where supply shortages made it legal under specific rules. That situation does not translate to the UK.

In the UK, the licensed semaglutide product for weight management is Wegovy. It arrives as a pre-filled injection pen. There is no powder to dissolve, no syringe to fill and nothing to measure. A patient loads the pen, selects the correct needle, and injects. That is the entire preparation. If you are being asked to mix anything at all, the product you are looking at is not the licensed UK medicine.

This is not a technicality. The manufacturing conditions, sterility controls and dose accuracy that govern a pre-filled pen produced under Good Manufacturing Practice are entirely absent when a powder is reconstituted at home or by an unregulated third party. The risks are real, and the MHRA has documented them.

What the MHRA has actually found in the UK market

Since 2023, the MHRA has seized large volumes of fake and unlicensed weight-loss injectable products being sold online and through social media. Early enforcement focused on counterfeit Ozempic and Saxenda pens. By late 2025, the agency had uncovered the first illicit UK manufacturing site producing counterfeit tirzepatide pens, and enforcement had recovered approximately 20 million doses of illegally traded medicines, with an estimated street value of around £45 million.

Some of the fake pens seized contained insulin rather than the claimed active ingredient, a life-threatening substitution for someone who does not have diabetes. Others were simply unsterile. The MHRA urges anyone who suspects a product or seller to report it through the Yellow Card scheme, which also accepts reports of suspected counterfeit medicines.

For readers who have come across instructions for mixing semaglutide and bacteriostatic water and are trying to understand whether it applies to them: it does not apply to licensed UK prescriptions. If someone has sold or offered you a powder form of semaglutide in the UK, that product exists outside the licensed supply chain.

What legitimately prescribed semaglutide actually looks like in the UK

Wegovy is supplied as a once-weekly subcutaneous injection, in a pre-filled pen. The prescribing schedule starts at 0.25 mg and is titrated upward by the prescriber, typically in four-week steps, up to the 2.4 mg maintenance dose. In April 2026, the MHRA approved a dedicated single-dose 7.2 mg pen, the higher maintenance option for eligible adults. At every stage, the dose is set by the prescriber, not chosen or measured by the patient.

The NHS semaglutide medicines page outlines how to use the pen correctly, including injection site rotation (abdomen, thigh or upper arm), and refers patients to the Patient Information Leaflet for storage details. If you want a broader overview of how semaglutide is used for weight management, the semaglutide overview covers the evidence and the licensed context in full.

One practical note worth knowing: the Wegovy pen does not require any assembly beyond attaching a needle. It is not the same as injecting a drug you have drawn up yourself, and the learning curve for most people is short. Our prescribers hear this anxiety regularly, nervousness about self-injection is entirely understandable, and the design of the licensed pen addresses most of it.

What if you read about mixing with sterile water instead?

Some sources distinguish between bacteriostatic water and sterile water as diluents for compounded semaglutide. If you have been looking into mixing semaglutide with sterile water, the context is the same: this applies to powdered, compounded semaglutide that does not have a UK marketing authorisation for weight management. Neither route is part of legitimate UK prescribing practice for Wegovy.

For anyone weighing up their options, the question worth sitting with is not which diluent to use, it is how to access semaglutide through a regulated pathway in the first place. Where and how to obtain Wegovy in the UK is a separate subject, but the short answer is: through a licensed pharmacy, on a valid prescription, following a clinical assessment by a qualified prescriber. The cost context, the NHS eligibility criteria and the private route are all covered on the weight-loss treatment overview.

If you have concerns about a product you have already received, or you experience unexpected reactions after injecting anything described as semaglutide, seek medical advice promptly. Reporting to the Yellow Card scheme helps the MHRA identify patterns and protect others.